BET Bromodomain Proteins as Cancer Therapeutic Targets
Author:
Publisher
Cold Spring Harbor Laboratory
Subject
Genetics,Molecular Biology,Biochemistry
Reference54 articles.
1. Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
2. Resistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers
3. MYC regulates the antitumor immune response through CD47 and PD-L1
4. Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
5. Modeling precision treatment of breast cancer
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines;Bioorganic & Medicinal Chemistry;2024-10
2. Synergistic effects of combined BET and FAK inhibition against Vestibular Schwannomas in NF2-related Schwannomatosis;Oncogene;2024-08-29
3. Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel;Cancers;2024-05-25
4. Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application;Journal of Medicinal Chemistry;2024-05-03
5. Disabled C3ar1/C5ar1 Signaling in Foxp3+ T Regulatory Cells Leads to TSDR Demethylation and Long-Term Stability;The Journal of Immunology;2023-09-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3